U.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns. Next, the CDC is to issue recommendations for using the vaccine.
The US Food and Drug Administration on Monday approved the first vaccine that protects newborns from respiratory syncytial virus, known as RSV. The vaccine, made by Pfizer, is given to mothers late in their pregnancies and provides protection to infants through their first six months of life.
Expectant parents could soon have another new option this fall to protect their newborns from RSV, the most common cause of hospitalization in American infants.
The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies.
The Food and Drug Administration on Monday approved Pfizer’s vaccine against the RSV virus for use in pregnant women so they pass to their newborns immunity from the resulting respiratory disease.
RSV is notorious for filling hospitals with wheezing babies every fall and winter. The FDA cleared Pfizer's maternal vaccination to guard against a severe case of RSV when babies are most vulnerable — from birth through 6 months of age.
The U.S. Food and Drug Administration (FDA) just approved Abrysvo, the first vaccine for pregnant individuals to prevent respiratory syncytial virus (RSV) infections in infants up to 6 months old.
The Food and Drug Administration (FDA) has approved the first vaccine for pregnant women to prevent RSV in infants, the agency announced on Monday. Abrysvo is made by Pfizer.
Abrysvo reduced the risk of lower respiratory tract illnesses, like pneumonia, by nearly 82% within infants' first 3 months of life, a clinical trial found
Abrysvo has been approved as a maternal vaccine to prevent lower respiratory tract disease (LRTD) in babies from birth through 6 months of age, according to the FDA’s press release.
The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies.
Showing the first 25 of 26 headlines. ·
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Food and Drug Administration approves 1st maternal RSV vaccine to help protect infants | Since Then
